KLOW

Description

KLOW is a laboratory-formulated research peptide blend supplied by AusPepLabs, combining four extensively studied research compounds – TB-500 (Thymosin Beta-4), BPC-157, GHK-Cu (Copper Tripeptide-1), and KPV (Lys-Pro-Val) – in a single 80mg lyophilized vial. Building on the GLOW blend with the addition of KPV, KLOW adds a fourth mechanistic dimension covering NF-κB pathway modulation and epithelial barrier biology research models. Each vial is independently verified to ≥99% HPLC purity with a Certificate of Analysis available on request. For scientific research use only.

Why Research Laboratories Select KLOW

KLOW expands on the GLOW blend by adding KPV – a synthetic α-MSH C-terminal tripeptide studied for its cellular uptake via the PepT1 oligopeptide transporter and NF-κB pathway interactions in intestinal epithelial cell models. This fourth component adds an inflammatory signaling and epithelial biology dimension to the three-pathway GLOW system, giving researchers a broader multi-pathway reference tool in a single 80mg lyophilized vial.

• Four-component blend – TB-500, BPC-157, GHK-Cu, and KPV in one 80mg lyophilized vial
• KPV addition – adds NF-κB pathway modulation and epithelial barrier biology to the GLOW framework
• Multi-pathway research system – cytoskeletal, gastrointestinal peptide, copper-dependent, and inflammatory signaling studied simultaneously
• GHK-Cu at 50mg dominant concentration – suited for extracellular matrix and copper-peptide research
• TB-500, BPC-157, and KPV at 10mg each – complementary pathway coverage
• Each component independently verified to ≥99% HPLC purity
• Lyophilized format ensures stability and reproducibility across experimental runs